SU14813 maleate is primarily used in the field of oncology research due to its potent inhibitory effects on multiple receptor tyrosine kinases. These kinases play a critical role in tumor growth, angiogenesis, and metastasis. The compound is often employed in preclinical studies to investigate its efficacy in blocking signaling pathways that promote cancer progression. Researchers utilize it to explore potential therapeutic strategies for various cancers, including renal cell carcinoma and glioblastoma. Additionally, SU14813 maleate is studied for its ability to enhance the effectiveness of other anticancer treatments when used in combination therapies. Its application extends to understanding the molecular mechanisms of drug resistance and developing targeted cancer therapies.